Professor Filippo Crea speaks with Cardio Debate and Radcliffe Cardiology about inflammation and coronary artery disease during the ESC Congress 2015 in London, UK
Inflammation&coronary artery disease: ‘The vulnerable plaque hypothesis is over’
Related articles
09/17/2018 - CANTOS One-Year Later - Prof Paul Ridker, Harvard Medical School, USA
09/12/2018 - CANTOS Update: IL-6 inhibition reduces atherothrombotic events - Sian Claire Owen, medical journalist for Cardio Debate, UK
02/26/2018 - Inflammation and Cardiovascular Disease – CANTOS and beyond - Prof JC Kaski, St George's, University of London, UK
06/11/2017 - Renin angiotensin system inhibitors: to use or not to use? - Dr Rachel Bastiaenen, PhD, St Paul’s Hospital Vancouver, Canada
07/04/2016 - HF-PEF Syndrome & Coronary Artery Spasm - Prof Filippo Crea, Catholic University of Rome, Italy
06/27/2016 - Ranolazine for management of microvascular angina - Prof Juan Carlos Kaski, St George's, University of London, UK
02/08/2016 - Inflammation in atherogenesis and plaque disruption - Professor Göran Hansson, Centre for Molecular Medicine, Karolinska University Hospital, Sweden
01/28/2016 - Inflammation and Ischaemic Heart Disease - Prof Robin Choudhury, University of Oxford and John Radcliffe Hospital, Oxford, UK
01/04/2016 - Dual antiplatelet therapy in unstable angina – Prof Gislasen - Professor Gunnar Gislasen, Gentofte University Hospital, Denmark
12/28/2015 - Sudden Cardiac Death Syndrome in South Asians living in the UK - Dr Rajay Narain, Clinical and Research Cardiologist, St George’s University of London, UK
Leave a Reply
You must be logged in to post a comment.